Bilingual text here: https://english.ftvnews.com.tw/news/2026319W07EA?utm_source=youtube&utm_medium=description
雙語文字版: https://english.ftvnews.com.tw/news/2026319W07EA?utm_source=youtube&utm_medium=description
Our official website: ➔ https://english.ftvnews.com.tw/
Follow us on
Facebook: ➔ https://www.facebook.com/ftvformosanews
X (Twitter): ➔ https://x.com/FTV_Taiwan_News
Nearly 7 million people in Taiwan suffer from fatty liver disease, making it the most common type of liver disease in the country. The condition is also highly associated with cardiovascular disease, cirrhosis, and even liver cancer. But now there are new breakthroughs in treatment. The Advancing Clinical Treatment of Liver Disease association, or ACT-LD, has introduced a “traffic light” system of metabolic indicators to help the public to assess their liver health.
Indulging in sugary and fatty foods is a common pitfall for many. And with stagnant lifestyles that prioritize lying down over sitting and sitting over standing, be careful—you might be at risk of developing fatty liver disease.
Kao Jia-horng
ACT-LD president
In Taiwan, about one-third of people have fatty liver disease. Of them, approximately 10% will develop inflammation associated with fatty liver. We know that inflammation is a key stop on the way to cirrhosis and liver cancer. Therefore, as soon as there’s inflammation, you should go consult a specialist.
There are nearly 7 million people in Taiwan with fatty liver disease, making it the most common liver affliction in Taiwan. It’s also a critical indicator for serious cardiovascular disease and liver cancer. For people with liver fibrosis, there has long been a lack of effective treatments. But fortunately, new medical breakthroughs have emerged.
Liu Chun-jen
NTU Hospital physician
After Phase III large-scale clinical trials, it has been confirmed that this treatment can effectively improve inflammation associated with fatty tissue and fibrosis scarring. In February, we obtained a trial permit from the Ministry of Health and Welfare. This is a significant breakthrough.
Fatty liver inflammation often has no obvious symptoms in the early stages, making it easy to miss the optimal treatment window. To help people take an active role in monitoring their liver health, check out ACT-LD’s traffic light system for metabolic indicators.
For more Taiwan news, tune in:
Mon to Fri at 9:30 pm on Channel 152
Tue to Sat at 1 am on Channel 53
#liverdisease #fattyliverdisease #health #publichealth #cirrhosis #doctors #ACT-LD #livercancer
#台灣新聞 #TaiwanNews #民視新聞 #FTV新聞 #Taiwan
